September 7, 2006 The prestigious Journal of Medicinal Chemistry published the initial results from DesignMedix's proprietary technology:  A Chloroquine-like molecule designed to Reverse Resistance in Plasmodium falciparum. J Med Chem, 2006 September 6; 49(18) 5623-5625. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2215738